Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DNA

Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DNA
DateTimeSourceHeadlineSymbolCompany
12:00PMiHub NewswireFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
04/16/20247:02AMPR Newswire (US)Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery ProductsNYSE:DNAGinkgo Bioworks Holdings Inc
04/11/20247:01AMPR Newswire (US)Ginkgo Bioworks Announces Acquisition of AgBiome's Platform AssetsNYSE:DNAGinkgo Bioworks Holdings Inc
04/11/20247:01AMPR Newswire (US)Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"NYSE:DNAGinkgo Bioworks Holdings Inc
04/10/20247:02AMPR Newswire (US)Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value ChainNYSE:DNAGinkgo Bioworks Holdings Inc
04/10/20247:01AMPR Newswire (US)Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles OutbreaksNYSE:DNAGinkgo Bioworks Holdings Inc
04/08/20247:00AMPR Newswire (US)IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing ServiceNYSE:DNAGinkgo Bioworks Holdings Inc
04/04/20247:01AMPR Newswire (US)Ginkgo Bioworks to Host 5th Annual Ferment ConferenceNYSE:DNAGinkgo Bioworks Holdings Inc
04/03/20247:02AMPR Newswire (US)Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API ManufacturingNYSE:DNAGinkgo Bioworks Holdings Inc
04/02/20247:02AMPR Newswire (US)Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR DesignsNYSE:DNAGinkgo Bioworks Holdings Inc
03/28/20247:02AMPR Newswire (US)Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather EnvironmentsNYSE:DNAGinkgo Bioworks Holdings Inc
03/27/20247:02AMPR Newswire (US)AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood ProductionNYSE:DNAGinkgo Bioworks Holdings Inc
03/26/20247:02AMPR Newswire (US)Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy ProteinsNYSE:DNAGinkgo Bioworks Holdings Inc
03/12/20247:01AMPR Newswire (US)CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and ChicagoNYSE:DNAGinkgo Bioworks Holdings Inc
03/12/20247:00AMGlobeNewswire Inc.CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and ChicagoNYSE:DNAGinkgo Bioworks Holdings Inc
03/11/202410:55AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/08/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/08/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/08/202410:27AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/07/202410:09AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/06/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/06/202410:04AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/05/202412:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/04/20247:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/04/202412:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
03/01/20242:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
02/29/20245:03PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
02/29/20245:01PMPR Newswire (US)Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
02/29/202412:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
02/28/202411:22AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
 Showing the most relevant articles for your search:NYSE:DNA